The Controversy Over Antidepressant Drugs in an Era of Evidence-Based Practice

Social Work in Mental Health

Volumn 10, Issue 6, 2012, Pages 445-463

  Littrell, Jill Leslie ^a   Lacasse, Jeffrey R ^b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

antidepressant efficacy; antidepressants; evidence based practice (EBP)

Indexed keywords

EID: 84866665509     PISSN: 15332985     EISSN: 15332993     Source Type: Journal    
DOI: 10.1080/15332985.2012.699444     Document Type: Article

References (122)

1. Andrews, P.W., Kornstein, S.G., Halberstadt, L.J., Gardner, C.O. and Neale, M.C. 2011. Blue again; perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Frontiers in Psychology, 2(159): 1-24.
2. Andersohn, F., Schade, R., Suissa, S. and Garbe, E. 2009. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. American Journal of Psychiatry, 166(5): 591-598.
3. Angell, M. 2011a. Why there is an epidemic of mental illness. New York Review of Books, LVIII(11) June 23: 20-22.
4. Angell, M. 2011b. The illusion of psychiatry. New York Review of Books, LVIII(12) July 14: 20-22.
5. Angell, M. 2011c. The illusion of psychiatry: An exchange. New York Review of Books, LVIII(13) August 18: 82-84.
6. Beck, A.T. 1967. Depression: Causes and treatment, Philadelphia, PA: University of Pennsylvania Press.
7. Bentley, K.J., Walsh, J. and Farmer, R. 2005. Referring clients for psychiatric medication: Best practices for social workers. Best Practices in Mental Health, 1(1): 59-71.
8. Blackburn, I.M. and Moore, R.G. 1997. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy inn out-patients with recurrent depression. British Journal of Psychiatry, 171(10): 328-334.
9. Bliziotes, M. 2010. Update on serotonin and bone. Journal of Clinical Endocrinology and Metabolism, 95(9): 2124-4132.
10. Bockting, C.L., Ten Doesschate, M.C., Spijker, J., Spinhoven, P., Koeter, M.W. and Schene, A.H. 2006. Continuation and maintenance use of antidepressants in recurrent depression. Psychotherapy and Psychosomatics, 77(1): 17-26.
11. Boyer, E.W. and Shannon, M. 2005. The serotonin syndrome. New England Journal of Medicine, 352(11): 1112-1117.
12. Brugha, T.S., Bebbington, P., McCarthy, B., Stuart, E. and Wykes, T. 1992. Antidepressants may not assist recovery in practice: A naturalistic prospective survey. Acta Psychiatrica Scandanavia, 86: 5-11.
13. Byrne, S.E. and Rothchild, A.J. 1998. Loss of antidepressant efficacy during maintenance therapy. Journal of Clinical Psychiatry, 59: 729-788.
14. Casey, D.E. 2006. Implications of the CATIE trial on treatment: Extrapyramidal symptoms. CNS Spectrum, 11(Supplement 7): 25-31.
15. Ceccherini-Nelli, A., Bardellini, L., Cur, A., Guazzelli, M., Maggini, C. and Dilsaver, S.C. 1993. Anti-depressant withdrawal: prospective findings. American Journal of Psychiatry, 150: 165
16. Chambers, C.D., Hernandez-Diaz, S., Van Marter, L.J., Werier, M.M., Louik, C., Jones, K.L. and Mitchell, A.A. 2006. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. New England Journal of Medicine, 354(6): 579-587.
17. Cohen, J.A. 2003. Managed care and the evolving role of the clinical social worker in mental health. Social Work, 48(1): 34-43.
18. Coryell, W., Akiskal, H.S., Leon, A.C., Winokur, G., Maser, J.D., Mueller, T.I. and Keller, M.B. 1994. The time course of nonchronic major depressive disorder. Uniformity across episodes and samples. Archives of General Psychiatry, 51: 405-410.
19. Croen, L.A., Grether, J.K., Yoshida, C.K., Odouli, R. and Hendrick, V. 2011. Antidepressant use during pregnancy and childhood autism spectrum disorders. Archives of General Psychiatry, 68(11): 1104-1112.
20. Csoka, A.B., Bahrick, A. and Mehtonen, O.P. 2008. Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors. Journal of Sexual Medicine, 5(1): 227-233.
21. Dai, J., Miller, A.H., Bremner, J.D., Goldberg, J., Jones, L., Shallenberger, L. and Vaccarino, V. 2008. Adherence to the mediterranean diet is inversely associated with circulating interleukin-6 among middle-aged men: A twin study. Circulation, 117(2): 169-175.
22. Damsa, C., Bumb, A., Bianchi-Demicheli, F., Vidailhet, P., Sterck, R., Andreoli, A. and Beyenburg, S. 2004. "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review. Journal of Clinical Psychiatry, 65(8): 1064-1068.
23. Dannon, P.N., Iancu, I., Lowengrub, K., Gonopolsky, Y., Musin, E. and Grunhaus, L.A. 2007. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder. Clinical Neuropharmacology, 30: 326-334.
24. Dawood, T., Lambert, E.A., Barton, D.A., Laude, D., Elghozi, J.L., Esler, M.D., Haikerwal, D., Kaye, D.M., Hotchkin, E.J. and Lambert, G.W. 2007. Specific serotonin reuptake inhibitors in major depressive disorder adversely affects novel cardiac risk. Hypertension Research, 30: 285-293.
25. DeRubeis, R.J., Fournier, J.C. and Fawcett, J. 2010. Depression severity and effects of antidepressant medications. Journal of the American Medical Association, 303(16): 1599
26. DeRubeis, R.J., Gelfand, L.A., Tang, T.Z. and Simons, A.D. 1999. Medications versus cognitive behavior therapy for severely depressed outpatients: Mega-analysis of four randomized comparisons. American Journal of Psychiatry, 156: 1007-1013.
27. Elkin, I., Shea, T., Watkins, J.T., Imber, S.D., Sotsky, S.M., Collins, J.F., Glass, D.R., Pilkonis, P.A., Leber, W.R., Docherty, J.P., Fiester, S.J. and Parloff, M.B. 1989. National Institute of Mental Health treatment of depression collaborative research program. Archives of General Psychiatry, 46: 971-982.
28. Evans, M.D., Hollon, S.D., DeRubeis, R.J., Piasecki, J.M., Grove, W.M., Garvey, M.J. and Tuason, V.B. 1992. Differential relapse following cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry, 49: 802-808.
29. Fava, G.A. 2003. Can long-term treatment with antidepressant drugs worsen the course of depression?. Journal of Clinical Psychiatry, 64: 123-133.
30. Fava, G.A. and Offidani, E. 2011. The mechanisms of tolerance in antidepressant action. Progress in Neuro-Psychopharmacology & Biological Psychiatry, doi:S0278-5846(10)00292-7 [pii]
31. Fava, M. 2000. Weight gain and antidepressants. Journal of Clinical Psychiatry, 61(Supplement 11): 37-41.
32. Fava, M. 2006. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. Journal of Clinical Psychiatry, 67: 1754-1759.
33. Fountoulakis, K.N. and Möller, H.-J. 2011. Efficacy of antidepressants: A re-analysis and re-interpretation of the Kirsch data. Journal of Neuropsychopharmacology, 14: 405-412.
34. Fournier, J.C., DeRubeis, R.J., Hollon, S.D., Dimidjian, S., Amsterdam, J.D., Shelton, R.C. and Fawcett, J. 2010. Antidepressant drug effects and depression severity: A patient-level meta-analysis. Journal of the American Medical Association, 303(1): 47-53.
35. Frank, E., Kupfer, D.J. and Perel, J.M. 1989. Early recurrence in unipolar depression. Archives of General Psychiatry, 46: 397-400.
36. Geddes, J.R., Carney, S.M., Davies, C., Furukawa, T.A., Kupfer, D.J., Frank, E. and Goodwin, G.M. 2003. Relapse prevention with antidepresant treatment in depressive disorders: A systematic review. Lancet, 361(9358): 653-661.
37. Gentile, S. 2011. Drug treatment for mood disorders in pregnancy. Current Opinion in Psychiatry, 24(1): 34-40.
38. Glenmullen, J. 2005. The antidepressant solution: a step-by-step guide to safely overcoming antidepressant withdrawal, dependence, and "addiction.", New York, NY: Free Press.
39. Gomory, T., Wong, S.E., Cohen, D. and Lacasse, J.R. 2011. Clinical social work and the biomedical industrial complex. Journal of Sociology and Social Welfare, 38(4): 135-165.
40. Greenwood, B.N. and Fleshner, M. 2008. Exercise, learned helplessness, and the stress-resistant brain. Neuromolecular Medicine, 10(2): 81-98.
41. Goldstein, T.R., Frye, M.A., Denicoff, K.D., Smith-Jackson, E., Leverich, G.S., Bryan, A.L., Ali, S.O. and Post, R.M. 1999. Antidepressant discontinuation-related mania: Critical prospective observation and theoretical implications in bipolar disorder. Journal of Clinical Psychiatry, 60: 563-567.
42. Haddad, P. 1997. New antidepressants and the discontinuation syndrome. Journal of Clinical Psychiatry, 58(Supplement 7): 17-21.
43. Hamer, M., Batty, G.D., Marmot, M.G., Singh-Manoux, A. and Kivimäki, M. 2011. Anti-depressant medication use and C-reactive protein: Results from two population-based studies. Brain, Behavior, and Immunity, 25: 168-173.
44. Healy, D. 1997. The antidepressant era, Cambridge, MA: Harvard University.
45. Ho, B.-C., Andreasen, N.C., Ziebell, S., Pierson, M.R. and Magnotta, V. 2011. Long-term antipsychotic treatment and brain volume. Archives of General Psychiatry, 68(2): 128-137.
46. Hoffman, B.M., Babyak, M.A., Craighead, W.E., Sherwood, A., Doraiswamy, P.M., Coons, M.J. and Blumenthal, J.A. 2011. Exercise and pharmacotherapy in patients with major depression: One-year follow-up of the SMILE study. Psychosomatic Medicine, 73(2): 127-133.
47. Hughes, S. and Cohen, D. 2009. A systematic review of long-term studies of drug treated and non-drug treated depression. Journal of Affective Disorders, 118: 9-18.
48. Insel, T.R. 2009. Disruptive insights in psychiatry: Transforming a clinical discipline. Journal of Clinical Investigation., 119(4): 700-705.
49. Judd, L.L., Akiskal, H.S., Maser, J.D., Zeller, P.J., Endicott, J., Coryell, W., Paulus, M.P., Kunovac, J.L., Leon, A.C., Mueller, T.L., Rice, J.A. and Keller, M.B. 1998. Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders, 50(2-3): 97-108.
50. Judd, L.L., Paulus, M.J., Schettler, P.J., Akiskal, H.S., Endicott, J., Leon, A.C., Maser, J.D., Mueller, T., Solomon, D.A. and Keller, M.B. 2000. Does incomplete recovery from the first lifetime major depressive episode herald a chronic course of illness. American Journal of Psychiatry, 157: 1501-1504.
51. Kawail, M. and Rosen, C.J. 2010. Minireview: A skeleton in serotonin's closet?. Endocrinology, 151(9): 4103-4108.
52. Keller, M.B., McCullough, J.P., Klein, D.N., Arnown, B., Dunner, D.L., Gelenberg, A.J., Markowitz, J.C., Nemeroff, C.B., Russell, J.M., Thase, M.E., Trivedi, M.H. and Zajecka, J. 2000. A comparison of nefazadone, the cognitive-behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine, 342(20): 1462-1470.
53. Keller, M.B., Trivedi, M.H., Thase, M.E., Shelton, R.C., Kornstein, S.G., Nemeroff, C.B., Friedman, E.S., Gelenberg, A.J., Kocsis, J.H., Dunner, D.L., Dunlop, B.W., Hirschfeld, R.M., Rothschild, A.J., Ferguson, J.M., Schatzberg, A.F., Zajecka, J.M., Pedersen, R., Yan, B., Ahmed, S., Schmidt, M. and Ninan, P.T. 2007. The prevent of recurrent episodes of depression with venlafaxine for two years (PREVENT) study: Outcomes from the acute and continuation phases. Biological Psychiatry, 62: 1371-1379.
54. Kemp, A.H., Quintana, D.S., Gray, M.A., Felmingham, K.L., Brown, K. and Gatt, J. 2010. Impact of depression and antidepressant treatment on heart rate variability: A review and meta-analysis. Biological Psychiatry, 67: 1067-1074.
55. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R. and Walters, E.E. 2005. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity survey replication. Archives of General Psychiatry, 62: 593-602.
56. Khan, A., Leventhal, R.M., Khan, S.R. and Brown, W.A. 2002. Severity of depresion and response to antidepressants and placebo: An analysis of the Food and Drug Administration database. Journal of Clincial Psychopharmacology, 22(1): 40-45.
57. Kiecolt-Glaser, J.K. 2010. Stress, food, and inflammation: Psychoneuroimmunology and nutrition at the cutting edge. Psychosomatic Medicine, 72(4): 365-369.
58. Kiecolt-Glaser, J.K., Belury, M.A., Andridge, R., Malarkey, W.B. and Glaser, R. 2011. Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial. Brain, Behavior, and Immunity, 25(8): 1725-1734.
59. Kirsch, I. 2010. The emperor's new drugs: Exploding the antidepressant myth, New York, NY: Basic Books.
60. Kivimäjum, N., Hamer, M., Batty, G.D., Geddes, J.R., Tabak, A.G., Pentti, J., Virtanen, M. and Vahtera, J. 2010. Antidepressant medication use, weight gain, and risk of Type 2 diabetes. Diabetes Care, 33(12): 2611-2616.
61. Klein, D.F., Gittelman, R., Quitkin, F. and Rifkin, A. 1980. Diagnosis and drug treatment of psychiatric disorders: Adults and children, 2nd, Baltimore, MD: Williams and Wilkins.
62. Konopaske, G.T., Dorph-Petersen, K.-A., Pierri, J.N., Wu, Q., Sampson, A. R. and Lewis, D. A. 2007. Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of the macaque monkeys. Neuropsychopharmacology, 32: 1216-1223.
63. Konopaske, G.T., Dorph-Petersen, K.-A., Sweet, R.A., Pierri, J.N., Zhang, W., Sampson, A.R. and Lewis, D.A. 2008. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biological Psychiatry, 63: 759-765.
64. Kubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J. and Maes, M. 2011. In animal models, psychosocial stress-induced (neuro) inflammation, apoptosis, and reduced neurogenesis are associated to the onset of depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35: 744-759.
65. Lacasse, J.R. and Leo, J. 2006. Questionable advertising of psychotropic medications and disease mongering. PLoS Medicine, 3(7): 1192
66. Laje, G., Paddock, S., Manji, H., Rush, A.J., Wilson, A.F., Charney, D. and McMahon, F.J. 2007. Genetic marker of suicidal ideation emerging during citalopram treatment of major depression. American Journal of Psychiatry, 164: 1530-1538.
67. Lejoyeux, M. and Adès, J. 1997. Antidepressant discontinuation: A review of the literature. Journal of Clinical Psychiatry, 58(Supplement 7): 11-15.
68. Lehmann, H.E. 1983. Clinical evaluation and natural course of depression. Journal of Clinical Psychiatry, 44: 5-10.
69. Leo, R.J. 1996. Movement disorders associated with the selective serotonin reuptake inhibitors. Journal of Clinical Psychiatry, 57(10): 449-454.
70. Leon, A.C., Hedeker, D. and Teres, J.J. 2007. Bias reduction in effectiveness analyses of longitudinal ordinal doses with a mixed-effects propensity adjustment. Statistics in Medicine, 26: 110-123.
71. Leon, A.C., Solomon, D.A., Mueller, T.I., Endicott, J., Rice, J.P., Maser, J.D., Coryell, W. and Keller, M.B. 2003. A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness. American Journal of Psychiatry, 160: 727-733.
72. Licht, C.M.M., de Gues, E.J.C., Zitman, F., Hoogendijk, W.J.G., van Dyck, R. and Penninx, B.W.J.H. 2008. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Archives of General Psychiatry, 65(12): 1358-1367.
73. Littrell, J. and Ashford, J. 1995. Can psychologists legally discuss medications with clients and when do they have a duty to do so?. Professional Psychology: Research and Practice, 26: 238-244.
74. Littrell, J. 1994. Relationship between time since reuptake-blocker antidepressant discontinuation and relapse. Experimental and Clinical Psychopharmacology, 2(1): 82-94.
75. Littrell, J. 2004. Obtaining informed consent when a profession labels itself as treating mental illness. Social Work in Mental Health, 1(4): 107-122.
76. Loke, Y.K., Trivedi, A.N. and Singh, S. 2008. Meta-analysis: Gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Alimentary Pharmacology & Therapeutics, 27: 31-40.
77. Maes, M. 2011. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Progress is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Progress in Neuropsychopharmacology, 35(3): 664-675.
78. Manschreck, T.C. and Boshes, R.A. 2007. The CATIE schizophrenia trial: Results, impact, and controversy. Harvard Review of Psychiatry, 15(5): 245-258.
79. McCabe, C., Mishor, Z., Cowen, P.J. and Harmer, C.J. 2010. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biological Psychiatry, 67(5): 439-445.
80. McGrath, P.J., Stewart, J.W., Tricamo, E., Nunes, E.N. and Quitkin, F.M. 1993. Paradoxical mood shifts to euthytmia or hypomania upon withdrawal of antidepressant agents. Journal of Clinical Psychopharmacology, 13(3): 224-225.
81. McIntyre, R., McCann, S.M. and Kennedy, S.H. 2001. Antipsychotic metabolic effects: Weight gain, diabetes mellitus, and lipid abnormalities. Canadian Journal of Psychiatry, 46(3): 273-281.
82. Mechanic, D. 2008. Mental health and social policy: Beyond managed care, 5th, New York, NY: Allyn & Bacon.
83. Miller, D.D., EcVoy, J.P., Davis, S.M., Caroff, S.N., Saltz, B.L., Chakos, M.H., Swartz, M.S., Keefe, R.S., Rosenheck, R.A., Stroup, T.S. and Lieberman, J.A. 2005. Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trail. Schizophrenia Research, 80(1): 33-43.
84. Moffitt, T.E., Caspi, A., Taylor, A., Kokaua, J., Milne, B.J., Polanczyk, G. and Poulton, R. 2009. How common are mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychological Medicine, 40: 899-909.
85. Moore, T.J., Glenmullen, J. and Furberg, C.D. 2010. Prescription drugs associated with reports of violence towards others. PloS ONE, 5(12): 15337
86. Mueller, T.I., Leon, A.C., Keller, M.B., Solomon, D.A., Endicott, J., Coryell, W., Warshaw, M. and Maser, J.D. 1999. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. American Journal of Psychiatry, 156(7): 1000-1006.
87. NASW Center for Workforce Studies. 2008. Social workers at work, Washington, DC: NASW Press.
88. Nation Institute for Clinical Excellence (NICE). (2009). Depression: The treatment and management of depression in adults. http://www.webcitation.org/66XJTiQ0v.
89. Nemeroff, C.B. 2001. Progress in the battle with the black dog: Advances in the treatment of depression. American Journal of Psychiatry, 158(10): 1555-1557.
90. Nierenberg, A.A., Ostacher, M.J., Huffman, J.C., Ametrano, R.M., Fava, M. and Perlis, R.H. 2008. A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder. Journal of Organizational and Environmental Medicine, 50: 428-436.
91. Osheroff v. Chestnut Lodge Inc. et al. 490 A.2d 720-724. MD. APP., April 10, 1985. NO1016 September term 1984,
92. Pato, M.T., Zohar-Kadouch, R., Zohar, J. and Murphy, D.L. 1988. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. American Journal of Psychiatry, 145: 1521-1525.
93. Physicians Desk Reference, 66th 2012 PDR.net
94. Post, R.M., Denicoff, K.D. and Leverich, G.S. 1997. Drug-induced switching in bipolar disorder. CNS Drugs, 8: 352-265.
95. Pratt, L.A., Brody, D.J., & Gu, Q. (2011, October). Antidepressant use in persons aged 12 and over: United States, 2005-2008. NCHS Data Brief, 76. www.cdc.gov/nchs/data/datbriefs/.
96. Psychiatric News Alert. (2011, July 21). FDA orders new warning on Seroquel label. http://alert.psychiatricnews.org/2011/03/fda-order-new-warning-on-seroquel.html.
97. Raeder, M.B., Bjelland, I., Emil Vollset, S. and Steen, V.M. 2006. Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: The Hordaland Health Study. Journal of Clinical Psychiatry, 67(2): 1947-1982.
98. Raison, C.L., Capuron, L. and Miller, A.H. 2006. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends in Immunology, 27(1): 24-31.
99. Ronalds, C., Creed, F., Stone, K., Webb, S. and Tomenson, B. 1997. The outcome of anxiety and depressive disorders in general practice. British Journal of Psychiatry, 171: 427-433.
100. Rosen, R.C., Lane, R.M. and Menza, M. 1999. Effects of SSRIs on sexual function: A critical review. Journal of Clinical Psychopharmacology, 19(1): 67-85.
101. Rubin, R.R., Ma, Y., Peyrot, M., Marrero, D.G., Price, D.W., Barrett-Connor, E. and Knowler, W.C. 2010. Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcome study. Diabetes Care, 33(12): 2549-2551.
102. Sanchez-Villegas, A., Delgado-Rodriguez, M., Alonso, A., Schlatter, J., Lahortiga, F., Serra Majem, L. and Martinez-Gonzalez, M.A. 2009. Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Archives of General Psychiatry, 66(10): 1090-1098.
103. Serebruany, V.L. 2006. Selective serotonin reuptake inhibitors and increased bleeding risk: Are we missing something?. American Journal of Medicine, 119(2): 113-116.
104. Serretti, A. and Mandelli, L. 2010. Antidepressants and body weight: A comprehensive review and meta-analysis. Journal of Clinical Psychiatry, 71(10): 1259-1272.
105. Simons, A.D., Murphy, G.E., Levine, J.L. and Wetzel, R.D. 1986. Cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry, 43: 43-48.
106. Shea, M.T., Elkin, I., Imber, S.D., Sotsky, S.M., Watkins, J.T., Collins, J.F., Pilkonis, P.A., Beckman, E., Glass, D.R., Dolan, R.T. and Parloff, M.B. 1992. Course of depressive symptoms over follow-up: Findings from the National Institute of Mental Health Treatment of Depression Collaborative Study. Archives of General Psychiatry, 49(10): 782-787.
107. Solomon, D.A., Keller, M.B., Leon, A.C., Mueller, T.I., Shea, M.T., Warshaw, M., Maser, J.D., Coryell, W. and Endicott, J. 1997. Recovery from major depression. A 10-year prospective follow-up across multiple episodes. Archives of General Psychiatry, 54(11): 1001-1006.
108. Spijker, J., De Graaf, R., Bijl, R.V., Beekman, A.T.F., Ormel, J. and Nolen, W.A. 2002. Duration of major depressive episodes in the general population: Results from The Netherlands Mental Health Survey and Incidence Study. British Journal of Psychiatry, 181: 208-213.
109. Stahl, L. February 19 2012. 60 Minutes: Treating depression, February 19, New York, NY: CBS News. Correspondent
110. Stoesz, D. 2012. Book reviews: Unhinged/The emperor's new drugs/Anatomy of an epidemic. Research in Social Work Practice, 22(2): 243-246.
111. Stoukides, J.A. and Stoukides, C.A. 1991. Extrapyramidal symptoms upon discontinuation of fluoxetine. American Journal of Psychiatry, 148: 1263
112. Thase, M.E. (2002). Small effects are not trivial from a public health perspective. Psychiatric Times, 19(9). http://www.webcitation.org/66Jm7BslJ.
113. Thase, M.E., Haight, B.R., Richard, N., Rockett, C.B., Mitton, M., Modell, J.G., VanMeter, S., Harriett, A.E. and Wang, Y. 2005. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: A meta-analysis of original data from 7 randomized controlled trials. Journal of Clinical Psychiatry, 66(8): 974-981.
114. Tranter, R., O'Donovan, C., Chandarana, P. and Kennedy, S. 2002. Prevalence and outcome of partial remission in depression. Journal of Psychiatry and Neuroscience, 27(4): 241-247.
115. Turner, E.H., Matthews, A.M., Linardatos, E., Tell, R.A. and Rosentahl, R. 2008. Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine, 358: 252-260.
116. Udechuku, A., Nguyen, T., Hill, R. and Szego, K. 2010. Antidepressants in pregnancy: A systemic review. Australian and New Zealand Journal of Psychiatry, 44(11): 978-996.
117. Watkins, J.T., Leber, W.R., Imber, S.D., Collins, J.F., Elkin, I., Pilkonis, P.A., Sotsky, S.M., Shea, M.T. and Glass, D.R. 1993. Temporal course of change of depression. Journal of Consulting and Clinical Psychology, 61(5): 858-864.
118. Whitaker, R. 2010. Anatomy of an epidemic, New York, NY: Crown Publishers.
119. Williams, N., Simpson, A.N., Simpson, K. and Nahas, Z. 2009. Relapse rates with long-term antidepressant drug therapy: A meta-analysis. Human Psychopharmacology, 24: 401-408.
120. Wu, C.S., Wang, S.C., Cheng, Y.C. and Gau, S.S. 2011. Association of cerebrovascular events with antidepressant use: A case-crossover study. American Journal of Psychiatry, 168: 511-521.
121. Zis, A.P. and Goodwin, F.K. 1979. Major affective disorder as a recurrent illness. Archives of General Psychiatry, 36: 835-839.
122. Zhou, F.-M., Liang, Y., Salas, R., Zhang, L., De Biasi, M. and Dani, J.A. 2005. Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron, 46(4): 65-74.